Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone-Reference-Cited by-同舟云学术

Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone

Published:2010-03 Issue:2 Volume:25 Page:116-125
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Riedel M.,Schennach-Wolff R.,Musil R.,Dehning S.,Cerovecki A.,Opgen-Rhein M.,Matz J.,Seemüller F.,Obermeier M.,Engel R. R.,Müller N.,Möller H.-J.,Spellmann I.

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hup.1101/fullpdf

Reference67 articles.

1. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition;Akdede;J Clin Psychiatry,2006

2. Executive functions and cognitive deficits in schizophrenia: comparisons between probands, parents and controls in India;Bhatia;J Postgrad Med,2009

3. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder;Bilder;Am J Psychiatry,2002

4. Relationship between psychopathology and cognitive functioning in schizophrenia;Bozikas;Compr Psychiatry,2004

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quetiapine Moderates Doxorubicin-Induced Cognitive Deficits: Influence of Oxidative Stress, Neuroinflammation, and Cellular Apoptosis;International Journal of Molecular Sciences;2023-07-16

2. The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia;Neuropharmacology;2022-05

3. Drug-induced metabolic alterations in adipose tissue - with an emphasis in epicardial adipose tissue;Anais da Academia Brasileira de Ciências;2022

4. Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up;Psychoneuroendocrinology;2021-11

5. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study;Psychoneuroendocrinology;2020-12